Esthetic Outcome of Isolated Advancement Genioplasty With and Without Submental Liposuction in Treatment of Skeletal Chin Deficiency

Receding Chin Clinical Trial

Official title:

Measuring the Eshetic Difference Between Advancement Genioplasty With and Without Submental Liposuction in Treatment of Skeletal Chin Deficiency in Double Chin Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04283708
• Other study ID #: Omfs337
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 1, 2020
• Est. completion date: March 1, 2021

Study information

• Verified date: February 2020
• Source: Cairo University
• Contact: Mostafa Ibrahim Shindy, Phd
• Phone: 01121112222
• Email: M2shindy[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is to measure the eshetic outcome of of isolated advancement genioplasty with and without submental liposuction in treatment of skeletal chin deficiency in double chin patients

Description:

Many methods used to treat skeletal chin deficiency in double chin patients, the aim of this study is to measure the advancement genioplasty with and without submental liposuction

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 22
• Est. completion date: March 1, 2021
• Est. primary completion date: January 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• skeletal chin deficiency

• double chin patients

• Ages from 18 to 45

• systemic free

Exclusion Criteria:

• body mass index greater than 28

• ages greater than 45

• systemically diseased

Related Conditions & MeSH terms

• Receding Chin
• Retrognathia

Intervention

Procedure:
• Submental liposuction
Advancement Genioplasty With Submental Liposuction

Locations

Country	Name	City	State
Egypt	Marwan mohamed atef ahmed lotfy	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	% of patient satisfaction	scale of units/discrets	6 months postoperative